Equity markets registered a strong performance overall on Thursday, and our top performing news events from the session notched some particularly impressive gains. Our top performers clustered in the pharma sector this Thursday, with multiple firms announcing results that investors deemed likely to drive substantial revenue growth in the coming years.
Pharmaceutical product news items often generate some of NewsQuantified’s most explosive news-based stock gains: entire lucrative product lines emerge into the financial public’s view overnight. But APVO’s gains on the Thursday trading session, over 110%, are astonishing even within the volatile Pharma Development sector.
Aptevo is a biotechnology company specializing in developing immuno-oncology and hematology treatments. They announced the successful sale of three immunology product lines, WinRho SDF, HepaGam B, and VARIZIG, to Saol Therapeutics in a deal worth around $74.5M
Investors piled into the stock on the news, convinced that APVO’s recent sales confirm a recent spate of commercialization success stories from APVO’s early-stage development operations.
Pharmaceutical developer Iovance announced Thursday that the United States FDA has approved a “fast track” through the regulatory approval process for IOVA’s new adoptive cell therapy, a promising potential treatment for advanced melanoma.
The fast track process was approved in recognition of a lack of effective treatments for late stage melanoma and should substantially decrease time to market for Iovance. Investors drove the stock to 14%+ gains on the news.
3. UQM Technologies (UQM): Nice gains on the unveiling of new mobile power center products.
Investors bought UQM heavily on optimism regarding their unveiling of what UQM called a “revolutionary, multi-purpose vehicle, the first in a new class of electric work machines.” These new mobile power centers will provide mission-critical power in off grid contexts ranging from disaster response to maintenance. The new product was developed and released in conjunction with DANNAR.
Diverse Plays, Big Gains: All in a single news day.
A powerful news analytics platform like NewsQuantified not only makes it easy to track the news, but to quickly compare news events with key financial information.
Today’s plays make the power of this news-based trading approach clear. Two of these plays came from the pharma sector, but our system issues hundreds of profitable alerts every single week, representing stocks from every sector
No small investor could be expected to track all these companies, diverse across industry, market cap, and valuation.
Yet they were all at the top of a single easy to use dashboard in the NewsQuantified platform. We make it simple to find strong, diverse plays in any market environment. We put the explosive gains of pharma development in range of smart investors, whether or not they have specialist knowledge of the industry.
Click here to sign up for a free training today. You’ll see how easy to use our platform really is—and how many profitable trades it can unlock. We make the insights of the world’s best financial minds more accessible—and transparent—than ever before.